BL
AMPE

Bolton LP’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bolton LP’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1
Closed -$43K – 331
2013
Q3 		$43K Buy
+1
New +$1.93K 0.01% 204

Other funds holding AMPE

NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $27.4B AUM 24.17% 1-Year Est. Return

Bolton LP's AMPE Position: Q4 2013 in Review

Bolton LP sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2013, closing a stake of 107 shares — an estimated $240K sold.

Bolton LP first reported a position in AMPE in Q3 2013 and held it in 1 quarter. The position peaked at $240K in Q3 2013. 59 funds tracked by Wall St. Rank hold AMPE as of Q4 2013.

  • Bolton LP reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2013 after selling out during the quarter.
  • Bolton LP sold 107 Ampio Pharmaceuticals Inc. shares in Q4 2013, an estimated $240K.
  • Bolton LP first reported a position in Ampio Pharmaceuticals Inc. in Q3 2013 and held it in 1 quarter.
  • Bolton LP's Ampio Pharmaceuticals Inc. position peaked at $240K in Q3 2013.
  • 59 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2013.

Based on Bolton LP's 13F filing for Q4 2013, filed 13 Feb 2014.